| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |